BPC-157 5mg

Overview

BPC-157 (Body Protection Compound-157) is a synthetic pentadecapeptide consisting of 15 amino acids. It is derived from a partial sequence of a protein found in human gastric juice. First described in the early 1990s, it has since become one of the most extensively studied repair-related peptides in preclinical biology -- with more than 100 peer-reviewed animal model studies published to date. BPC-157 is stable in human gastric juice and demonstrates systemic activity when administered via multiple routes in animal models -- a property unusual among peptides of its size. Its mechanism is thought to involve upregulation of growth hormone receptors, modulation of nitric oxide (NO) systems, and VEGF-mediated angiogenic signaling. These converging pathways make it a uniquely versatile compound for researchers studying tissue repair cascades.

Primary Research Areas

• Musculoskeletal repair -- tendon-to-bone healing, ligament repair, and bone regeneration in rodent models. BPC-157 has shown accelerated recovery timelines in Achilles tendon transection and MCL injury models.
• Gastrointestinal research -- gastric mucosa protection, inflammatory bowel disease models, gut permeability and epithelial barrier function studies. Its gastric juice origin makes it uniquely relevant to GI research.
• Angiogenesis -- VEGF pathway interactions, new blood vessel formation in in-vitro and in-vivo wound models, and endothelial cell migration assays
• Neuroprotection -- dopaminergic and serotonergic system interactions in early CNS research, including traumatic brain injury and peripheral nerve transection models
• Anti-inflammatory pathways -- modulation of inflammatory cascade markers (TNF-alpha, IL-6, IL-10) in acute and chronic tissue injury models

Research has appeared in journals including the Journal of Physiology-Paris, Current Pharmaceutical Design, and World Journal of Gastroenterology.